PEPG compared with ARTV: revenue, margins and what each company keeps, and the suppliers and customers both name

PEPGPepGen Inc.

Mkt capRevenueRevenue

ARTVArtiva Biotherapeutics, Inc.

Mkt capRevenueRevenue

Compare

PEPGPepGen Inc.

ARTVArtiva Biotherapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

PEPGPepGen Inc.

2.24▼−8.57%

Mkt cap$169.7MRevenue—

ARTVArtiva Biotherapeutics, Inc.

4.10▼−2.86%

Regular sessionNov 5 '26

Mkt cap$206.3MRevenue$251,000Q1 FY24

Compare

Regular sessionNov 5 '26

PEPGPepGen Inc.

ARTVArtiva Biotherapeutics, Inc.

2.24▼−8.57%

Price

4.10▼−2.86%

$169.7M

Mkt cap

$206.3M

—

Revenue

$251,000Q1 FY24

PEPG2.24▼−8.57%vsARTV4.10▼−2.86%Regular sessionNov 5 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

PEPG: latest quarter not drawable. ARTV: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only PEPG 2

—MRCunlistedsupplier

—Oxford University Innovationunlistedsupplier

Shared 0

No shared counterparties.

Only ARTV 1

—GC Cellunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

PEPG, solidARTV, dashed